A new Co(III)-hypocrellin B complex with enhanced photonuclease activity

Hypocrellin B (HB), a naturally occurring photosensitizer, has been extensively and intensively studied as a promising photodynamic therapy (PDT) agent. In this work, a new Co(III) complex [Co₂(HB)(tmp)₄]⁴⁺ (tmp = 3,4,7,8-tetramethyl-1,10-phenanthroline) was designed and synthesized with HB as bridging ligand and tmp as terminal ligand. [Co₂HB(tmp)₄]⁴⁺ exhibits improved water solubility, enhanced absorptivity in the phototherapeutic window, increased binding affinity and DNA photocleavage capability toward dsDNA with respect to HB. The photodynamic activity of [Co₂(HB)(tmp)₄]⁴⁺ stems from its ¹O₂ photosensitization ability, in sharp contrast to [Cu₂(HB)(tmp)₂]²⁺ which relies on superoxide anion radical (O₂^-) and hydroxyl radical (·OH) to photocleave DNA, though the both complexes possess similar electrochemical properties. The remarkable difference between the photodynamic mechanisms of [Co₂(HB)(tmp)₄]⁴⁺ and [Cu₂(HB)(tmp)₂]²⁺ was discussed in detail.